Skip to main navigation
Skip to search
Skip to main content
The Hebrew University of Jerusalem Home
Approve / Request updates on publications
Link opens in a new tab
Search content at The Hebrew University of Jerusalem
Home
Profiles
Research units
Research output
Prizes
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene
ITALSGEN Consortium
, Genomic Translation for ALS Care (GTAC) Consortium
, ALS Sequencing Consortium
, NYGC ALS Consortium
, Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium
, SLAGEN Consortium
, French ALS Consortium
, Project MinE ALS Sequencing Consortium
Institute for Medical Research Israel-Canada (IMRIC)
Research output
:
Contribution to journal
›
Article
›
peer-review
555
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Genome-wide Analyses Identify KIF5A as a Novel ALS Gene'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Genome-wide Analysis
100%
ALS Gene
100%
Kinesin Superfamily
100%
Novel Genes
50%
Genome-wide Association Study
33%
Neurodegenerative Diseases
16%
Two-line
16%
Exome Sequencing
16%
Gain-of-function mutation
16%
Motor Domain
16%
Phenotypic Spectrum
16%
Tail Domain
16%
Hereditary Spastic Paraplegia
16%
Rare Variant Burden
16%
Familial ALS
16%
Charcot-Marie-Tooth Disease
16%
Burden Analysis
16%
Cargo Binding
16%
SPG10
16%
Medicine and Dentistry
Amyotrophic Lateral Sclerosis
100%
Kinesin
100%
Genome Wide Association Study
100%
Amino Terminal Sequence
10%
Carboxy Terminal Sequence
10%
Degenerative Disease
10%
Exome Sequencing
10%
Tail
10%
Loss of Function Mutation
10%
DeJerine-Sottas Disease
10%
Relative Survival
10%
Biochemistry, Genetics and Molecular Biology
Kinesin
100%
Genome Wide Association Study
100%
Genome-Wide Association Study
33%
C-Terminus
16%
N-Terminus
16%
Exome Sequencing
16%
Loss of Function Mutation
16%
Rare Variant
16%
Neuroscience
Amyotrophic Lateral Sclerosis
100%
Kinesin
100%
Genome-Wide Association Study
20%
Cytoskeletal Defects
20%
Amino Terminal Sequence
10%
C-Terminus
10%
Neurodegenerative Disorder
10%
Exome Sequencing
10%
Loss of Function Mutation
10%
Hereditary Spastic Paraplegia
10%